Elevation Pharmaceuticals, Inc.

ELEVATION

Inhaled Pharmaceutical preparations for the treatment of respiratory diseases, namely, asthma, emphysema, bronchitis, COPD, lower respiratory infections, pneumonia, tuberculosis, cystic fibrosis, lung cancer, pulmonary fibrosis, bronchiectasis, byssinosis, bronchiolitis, asbestosis, fibrosis, sarcoidosis pleural effusion, hypersensitivity, pneumonitis, asbestosis, pleurisy, infant respiratory distress syndrome, acute respiratory distress syndrome, severe acute respiratory syndrome, pulmonary oedema, pulmonary embolism, pulmonary hypertension, and all upper respiratory infections, sold as a unit with pulmonary and intranasal drug delivery devices;